Editorial · 23 Jul 2022
EditorialPublished 2012
Molecularly Targeted Therapy: Great Progress or Evil Cycle
Subjects
Oncology & CancerSimilar by topic
Opinion · 5 Feb 2024
Molecular Targeting of Oncogenes: Progress and Challenges
Mini review · 30 Jun 2022
Cancer Therapy and Beyond: Current Standing, Drug Candidates, Associated Risks and Progress in Targeted Medical Specialty
Rapid communication · 28 Nov 2023
Molecular oncology research: exploring the molecular basis of cancer progression and therapy
Short communication · 6 Aug 2024
Gastric Carcinoma: Recent Trends in Diagnostic Biomarkers and Molecular Targeted Therapies
More from this journal
The newest in Chemotherapy: Open Access.
Perspective · 3 Nov 2025
Vulvar and Vaginal Cancers Clinical Characteristics Treatment Options and Prognosis
Opinion · 3 Nov 2025
Evaluation of Surgical Radiotherapy and Chemotherapy in the Treatment of Gynaecological Malignancies
Research article · 18 Aug 2025
Response Evaluation to Oxaliplatin-Based Adjuvant Chemotherapy after Curative Resection between Right and Left-Sided Stage II and III Colon Cancer: A Retrospective Survival Analysis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalChemotherapy: Open Access
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Yoh Dobashi”

